CN104548194A - Medical high-performance binding agent - Google Patents
Medical high-performance binding agent Download PDFInfo
- Publication number
- CN104548194A CN104548194A CN201410782457.2A CN201410782457A CN104548194A CN 104548194 A CN104548194 A CN 104548194A CN 201410782457 A CN201410782457 A CN 201410782457A CN 104548194 A CN104548194 A CN 104548194A
- Authority
- CN
- China
- Prior art keywords
- parts
- binding agent
- medical high
- vitamin
- medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention provides a medical high-performance binding agent. The medical high-performance binding agent is prepared from the following substances in parts by weight: 10-15 parts of polyisobutene, 5-15 parts of diethyl ether, 3-6 parts of hydroxyethyl methylacrylate, 1-2 parts of polyurethane, 4-7 parts of citrate, 1-1.5 parts of agar, 1-2 parts of vitamin, 0.3-0.5 part of fibrinogen and 10-15 parts of deionized water. The medical high-performance binding agent has the beneficial effects that the medical high-performance binding agent has the characteristics of high bonding strength, rapidness in bonding and no side effect and can assist healing of wound tissues of a living body, stimulation is small, and the requirements of a clinical medical binding agent are met.
Description
Technical field
The invention belongs to binding agent production technical field, be specifically related to a kind of medical high performance adhesive.
Background technology
Along with the progress of medical science, more and more higher to the requirement of surgical technic and auxiliary material effect clinically.The theory of modern medicine to reduce the misery of patient to greatest extent, allows patients ' recovery prestissimo, and while farthest restore funcitons, wish that outward appearance also can ideally be recovered.Therefore the continuous increase of clinical demand promoted adhesive of medical research development and adhering technique in clinical application.But current adhesive of medical can produce material bio-tissue being had to side effect in storage or use procedure, as formaldehyde etc., has a strong impact on the organized renewing ability of organism.
Summary of the invention
It is high that technical problem to be solved by this invention is to provide a kind of adhesion strength, and bonding is quick, and the medical high performance adhesive had no side effect.
For solving the problems of the technologies described above, the technical solution used in the present invention is:
A kind of medical high performance adhesive, it is made up of the material of following weight portion: polyisobutylene 10-15 part, ether 5-15 part, hydroxyethyl methylacrylate 3-6 part, polyurethane 1-2 part, citrate 4-7 part, agar 1-1.5 part, vitamin 1-2 part, fibrinogen 0.3-0.5 part, deionized water 10-15 part.
Preferably, above-mentioned binding agent is made up of the material of following weight portion: polyisobutylene 12 parts, ether 10 parts, hydroxyethyl methylacrylate 5 parts, polyurethane 1 part, citrate 5 parts, 1 part, agar, vitamin 1.5 parts, fibrinogen 0.4 part, deionized water 12 parts.
Wherein, above-mentioned vitamin is vitamin B3, vitamin B5 or vitamin B12.
Compared with prior art, the invention has the beneficial effects as follows: it is high that binding agent of the present invention has adhesion strength, fast, the feature had no side effect, can assist the healing of organism wound tissue simultaneously, stimulate little, reach the requirement of clinical medical binding agent bonding.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described in further details.
Embodiment 1
A kind of medical high performance adhesive, it is made up of the material of following weight portion: polyisobutylene 10 parts, ether 5 parts, hydroxyethyl methylacrylate 3 parts, polyurethane 1 part, citrate 4 parts, 1 part, agar, vitamin B3 1 part, fibrinogen 0.3 part, deionized water 10 parts.
Embodiment 2
A kind of medical high performance adhesive, it is made up of the material of following weight portion: polyisobutylene 12 parts, ether 10 parts, hydroxyethyl methylacrylate 5 parts, polyurethane 1 part, citrate 5 parts, 1 part, agar, vitamin B12 1.5 parts, fibrinogen 0.4 part, deionized water 12 parts.
Embodiment 3
A kind of medical high performance adhesive, it is made up of the material of following weight portion: polyisobutylene 15 parts, ether 15 parts, hydroxyethyl methylacrylate 6 parts, polyurethane 2 parts, citrate 7 parts, 1.5 parts, agar, vitamin B5 2 parts, fibrinogen 0.5 part, deionized water 15 parts.
Finally it should be noted that, the foregoing is only the preferred embodiments of the present invention, be not limited to the present invention, although with reference to previous embodiment to invention has been detailed description, for a person skilled in the art, it still can be modified to the technical scheme described in foregoing embodiments, or carries out equivalent replacement to wherein portion of techniques feature.Within the spirit and principles in the present invention all, any amendment done, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (3)
1. a medical high performance adhesive, it is characterized in that, this binding agent is made up of the material of following weight portion: polyisobutylene 10-15 part, ether 5-15 part, hydroxyethyl methylacrylate 3-6 part, polyurethane 1-2 part, citrate 4-7 part, agar 1-1.5 part, vitamin 1-2 part, fibrinogen 0.3-0.5 part, deionized water 10-15 part.
2. the medical high performance adhesive of one according to claim 1, it is characterized in that, this binding agent is made up of the material of following weight portion: polyisobutylene 12 parts, ether 10 parts, hydroxyethyl methylacrylate 5 parts, polyurethane 1 part, citrate 5 parts, 1 part, agar, vitamin 1.5 parts, fibrinogen 0.4 part, deionized water 12 parts.
3. the medical high performance adhesive of one according to claim 1 and 2, is characterized in that: described vitamin is vitamin B3, vitamin B5 or vitamin B12.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410782457.2A CN104548194A (en) | 2014-12-18 | 2014-12-18 | Medical high-performance binding agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410782457.2A CN104548194A (en) | 2014-12-18 | 2014-12-18 | Medical high-performance binding agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104548194A true CN104548194A (en) | 2015-04-29 |
Family
ID=53065956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410782457.2A Pending CN104548194A (en) | 2014-12-18 | 2014-12-18 | Medical high-performance binding agent |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104548194A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105708504A (en) * | 2016-03-08 | 2016-06-29 | 巢银苟 | Endoscopic extracting mesh basket and preparation method thereof |
| CN107890584A (en) * | 2017-11-29 | 2018-04-10 | 广西众昌树脂有限公司 | Medical adhesive composition |
| CN107899065A (en) * | 2017-11-29 | 2018-04-13 | 广西众昌树脂有限公司 | Medical adhesive compositions |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1359413A (en) * | 1999-03-09 | 2002-07-17 | 卫生与营养实验室 | Novel hydrocolloid adhesive mass with improved resistance to deterioration of its absorption capacity after being sterilised by radiation |
| US20050096611A1 (en) * | 2003-10-30 | 2005-05-05 | Stoyer Brian C. | Multi-adhesive medical appliance |
| CN102008745A (en) * | 2009-09-08 | 2011-04-13 | 张娟娟 | Medical pressure sensitive adhesive |
-
2014
- 2014-12-18 CN CN201410782457.2A patent/CN104548194A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1359413A (en) * | 1999-03-09 | 2002-07-17 | 卫生与营养实验室 | Novel hydrocolloid adhesive mass with improved resistance to deterioration of its absorption capacity after being sterilised by radiation |
| US20050096611A1 (en) * | 2003-10-30 | 2005-05-05 | Stoyer Brian C. | Multi-adhesive medical appliance |
| CN102008745A (en) * | 2009-09-08 | 2011-04-13 | 张娟娟 | Medical pressure sensitive adhesive |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105708504A (en) * | 2016-03-08 | 2016-06-29 | 巢银苟 | Endoscopic extracting mesh basket and preparation method thereof |
| CN107890584A (en) * | 2017-11-29 | 2018-04-10 | 广西众昌树脂有限公司 | Medical adhesive composition |
| CN107899065A (en) * | 2017-11-29 | 2018-04-13 | 广西众昌树脂有限公司 | Medical adhesive compositions |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2017163132A3 (en) | Use of umbilical cord blood derived exosomes for tissue repair | |
| RU2020121715A (en) | Synthesis of elastic fiber in vivo | |
| MX2014014840A (en) | Beta-hairpin peptidomimetics. | |
| MX2014004458A (en) | Threads of cross-linked hyaluronic acid and methods of use thereof. | |
| WO2012071526A3 (en) | Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds | |
| MX340276B (en) | Methods, system and apparatus for the detection, diagnosis and treatment of biological rhythm disorders. | |
| MX2010003019A (en) | Adherent cells from adipose or placenta tissues and use thereof in therapy. | |
| WO2012017166A3 (en) | Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf | |
| WO2010091376A3 (en) | Devices and methods for perfusion therapy | |
| EP2608797A4 (en) | Bone marrow derived cd271 precursor cells for cardiac repair | |
| MX2023005455A (en) | Methods of treating heart failure by administering omecamtiv mecarbil. | |
| CN104548194A (en) | Medical high-performance binding agent | |
| WO2014183033A3 (en) | G-csf for use in treating or preventing a disease associated with aging in a patient, for administration with a stem-cell containing composition and/or an electromagnetic signal | |
| WO2014016816A3 (en) | Polymeric mesh with selective permeability, for the repair and regeneration of tissues | |
| SG11201804755VA (en) | Method for manufacturing tissue/organ by using blood cells | |
| MX343205B (en) | Beta - hairpin peptidomimetics as cxc4 antagonists. | |
| BR112015004643A2 (en) | methods and compositions for hypotensive resuscitation | |
| WO2010118330A3 (en) | Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease | |
| WO2011138785A3 (en) | Use of ccl1 in therapy | |
| WO2016019350A3 (en) | Microscale bioprocessing system and method for protein manufacturing from human blood | |
| MX2021003798A (en) | Therapy with cells from human placenta and hematopoietic cells. | |
| CN201969076U (en) | Modified polylactic acid anti-adhesion biological film with chitosan | |
| CN202526408U (en) | Patch for treating skin rhagadia | |
| CN204070763U (en) | Magnetic therapy shoe | |
| CN205083746U (en) | Clamp plate for orthopedics department |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150429 |
|
| RJ01 | Rejection of invention patent application after publication |